Semaglutide provides the core metabolic benefits: appetite suppression, improved insulin sensitivity, reduced glucagon secretion, and delayed gastric emptying
The Dangers of Compounded GLP-1 Medications 1
SURMOUNT-MAINTAIN (Horn 2026, 112 weeks): continued top dose -21.9% vs 5 mg step-down -16.6% vs placebo -9.9%, rescue therapy 8/25/67%: Aronne JAMA 2024
Abdelnour SA, Alagawany M, Hashem NM, Farag MR, Alghamdi ES, Hassan FU, et al
These are diseases of the brain
1 Introduction Microorganisms derived from both the maternal body and the external environment begin to colonize the intestine at birth, progressively forming a structurally stable community known as the GM ( In 1976, esteemed researcher Genant et al